The path of least resistance: aggressive or moderate treatment?

The evolution of resistance to antimicrobial chemotherapy is a major and growing cause of human mortality and morbidity. Comparatively little attention has been paid to how different patient treatment strategies shape the evolution of resistance. In particular, it is not clear whether treating indiv...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kouyos, Roger D., Metcalf, C. Jessica E., Birger, Ruthie, Klein, Eili Y., Abel zur Wiesch, Pia, Ankomah, Peter, Arinaminpathy, Nimalan, Bogich, Tiffany L., Bonhoeffer, Sebastian, Brower, Charles, Chi-Johnston, Geoffrey, Cohen, Ted, Day, Troy, Greenhouse, Bryan, Huijben, Silvie, Metlay, Joshua, Mideo, Nicole, Pollitt, Laura C., Read, Andrew F., Smith, David L., Standley, Claire, Wale, Nina, Grenfell, Bryan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Royal Society 2014
Pynciau:
Review Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211439/
https://ncbi.nlm.nih.gov/pubmed/25253451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rspb.2014.0566
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg